To hear about similar clinical trials, please enter your email below
Trial Title:
Assessing Medical Trial Experiences of Hairy Cell Leukemia Patients
NCT ID:
NCT05859932
Condition:
Hairy Cell Leukemia
Conditions: Official terms:
Leukemia
Leukemia, Hairy Cell
Conditions: Keywords:
hairy cell leukemia
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
The percentages of participants in clinical studies haven't always been perfectly
representative of a particular group.
This research examines the variables that affect a patient's choice to enroll in,
discontinue participation in, or resume participation in a clinical trial for hairy cell
leukemia.
It will also try to analyze data from the perspective of different demographic groups to
check for recurring trends which might yield insights for the sake of hairy cell leukemia
studies.
Criteria for eligibility:
Study pop:
Patients who are actively considering involvement in an observational hairy cell leukemia
clinical trial, but have not yet completed enrollment and registration.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Aged ≥ 18 years old
- Ability to understand and the willingness to sign a written informed consent
document.
- Willing and able to comply with scheduled visits, treatment schedule, laboratory
tests and other requirements of the study.
Exclusion Criteria:
- Is pregnant, breastfeeding or expecting to conceive within the projected duration of
the study
- Any mental or medical condition that prevents the patient from giving informed
consent or participating in the trial
- Patients with any significant history of non-compliance to medical regimens or with
inability to grant a reliable informed consent.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
June 2024
Completion date:
June 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05859932
